🇺🇸 lumefantrine-artemether in United States
4 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 4
Most-reported reactions
- Anaemia — 1 report (25%)
- Exposure During Pregnancy — 1 report (25%)
- Live Birth — 1 report (25%)
- Small For Dates Baby — 1 report (25%)
Other Infectious Disease approved in United States
Frequently asked questions
Is lumefantrine-artemether approved in United States?
lumefantrine-artemether does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for lumefantrine-artemether in United States?
Centers for Disease Control and Prevention is the originator. The local marketing authorisation holder may differ — check the official source linked above.